Levomenol
Levomenol is a small molecule pharmaceutical. It is currently being investigated in clinical studies.
Download report
Favorite
Searched
Commercial
Therapeutic Areas
No data
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
No data
Labels
FDA
EMA
Brand Name | Status | Last Update |
|---|---|---|
| purpleu baobab face | unapproved drug other | 2017-12-08 |
Indications
FDA
EMA
No data
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
No data
HCPCS
No data
Clinical
Clinical Trials
636 clinical trials
View more details
Mock data
Subscribe for the real data
Subscribe for the real data
Indications Phases 4
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Colorectal neoplasms | D015179 | 29 | 122 | 79 | 1 | 8 | 227 | ||
| Stomach neoplasms | D013274 | EFO_0003897 | C16 | 15 | 33 | 9 | 1 | 3 | 56 |
| Adenocarcinoma | D000230 | 7 | 22 | 10 | 1 | 1 | 36 | ||
| Toxoplasmosis | D014123 | EFO_0007517 | B58 | 1 | — | — | 1 | — | 2 |
Indications Phases 3
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Neoplasms | D009369 | C80 | 28 | 24 | 10 | — | — | 59 | |
| Pancreatic neoplasms | D010190 | EFO_0003860 | C25 | 22 | 34 | 8 | — | 1 | 55 |
| Rectal neoplasms | D012004 | 13 | 20 | 9 | — | 1 | 41 | ||
| Lymphoma | D008223 | C85.9 | 5 | 20 | 10 | — | 3 | 37 | |
| Colonic neoplasms | D003110 | C18 | 10 | 14 | 13 | — | 1 | 35 | |
| Precursor cell lymphoblastic leukemia-lymphoma | D054198 | C91.0 | 5 | 16 | 15 | — | 2 | 34 | |
| Leukemia | D007938 | C95 | 2 | 20 | 10 | — | 2 | 34 | |
| Esophageal neoplasms | D004938 | C15 | 8 | 16 | 2 | — | 1 | 24 | |
| Hiv infections | D015658 | EFO_0000764 | B20 | 5 | 2 | 8 | — | 8 | 23 |
| Pancreatic ductal carcinoma | D021441 | 7 | 7 | 2 | — | — | 14 |
Show 32 more
Indications Phases 2
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Sarcoma | D012509 | 3 | 5 | — | — | — | 8 | ||
| Cerebral toxoplasmosis | D016781 | EFO_0007200 | B58.2 | 2 | 2 | — | — | 1 | 5 |
| Renal cell carcinoma | D002292 | 3 | 3 | — | — | — | 5 | ||
| Central nervous system neoplasms | D016543 | 1 | 3 | — | — | 1 | 5 | ||
| Ovarian neoplasms | D010051 | EFO_0003893 | C56 | 2 | 2 | — | — | — | 4 |
| Acinar cell carcinoma | D018267 | 2 | 2 | — | — | — | 4 | ||
| Osteosarcoma | D012516 | 1 | 3 | — | — | 1 | 4 | ||
| Myelodysplastic syndromes | D009190 | D46 | 2 | 2 | — | — | — | 4 | |
| Bile duct neoplasms | D001650 | 1 | 2 | — | — | — | 3 | ||
| Biphenotypic leukemia acute | D015456 | C95.0 | 1 | 3 | — | — | — | 3 |
Show 40 more
Indications Phases 1
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Gastrointestinal stromal tumors | D046152 | EFO_0000505 | C49.A | 3 | — | — | — | — | 3 |
| Non-small-cell lung carcinoma | D002289 | 3 | — | — | — | — | 3 | ||
| Lung neoplasms | D008175 | C34.90 | 3 | — | — | — | — | 3 | |
| Triple negative breast neoplasms | D064726 | 2 | — | — | — | — | 2 | ||
| Fallopian tube neoplasms | D005185 | 2 | — | — | — | — | 2 | ||
| Hepatitis c | D006526 | B19.2 | 2 | — | — | — | — | 2 | |
| Glioblastoma | D005909 | EFO_0000515 | 2 | — | — | — | — | 2 | |
| Myeloid leukemia acute | D015470 | C92.0 | 1 | — | — | — | — | 1 | |
| Squamous cell carcinoma of head and neck | D000077195 | 1 | — | — | — | — | 1 | ||
| Peritoneal neoplasms | D010534 | 1 | — | — | — | — | 1 |
Show 12 more
Indications Without Phase
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
|---|---|---|---|---|---|---|---|---|---|
| Juvenile arthritis | D001171 | EFO_0002609 | M08 | — | — | — | — | 1 | 1 |
| Obesity | D009765 | EFO_0001073 | E66.9 | — | — | — | — | 1 | 1 |
| Type 2 diabetes mellitus | D003924 | EFO_0001360 | E11 | — | — | — | — | 1 | 1 |
| Appetitive behavior | D001070 | — | — | — | — | 1 | 1 | ||
| Healthy diet | D000072001 | — | — | — | — | 1 | 1 |
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
| Drug common name | LEVOMENOL |
| INN | levomenol |
| Description | (-)-alpha-Bisabolol is a sesquiterpenoid. |
| Classification | Small molecule |
| Drug class | — |
| Image (chem structure or protein) | |
| Structure (InChI/SMILES or Protein Sequence) | CC(C)=CCC[C@](C)(O)[C@@H]1CC=C(C)CC1 |
Identifiers
| PDB | — |
| CAS-ID | 23089-26-1 |
| RxCUI | 1306126 |
| ChEMBL ID | CHEMBL1096927 |
| ChEBI ID | 125 |
| PubChem CID | 442343 |
| DrugBank | DB13153 |
| UNII ID | 24WE03BX2T (ChemIDplus, GSRS) |
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 30 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
2,883 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more